What's Going On With Revolution Medicines Stock?

on MSN ago, source:

Revolution Medicines, Inc. (NASDAQ:RVMD) shares are trading higher Wednesday. The company announced the publication of ...

Revolution Medicines Receives Buy Rating Amid Promising Cancer Treatment Data and Expanded Market Opportunities

3d ago, source:

Analyst Ami Fadia of Needham maintained a Buy rating on Revolution Medicines (RVMD – Research Report), boosting the price target to ...

Revolution Medicines: An Expensive Shot At A Massive Market Opportunity

4d ago, source:

Revolution is pioneering a unique precision-based approach to developing oncology drugs that target the RAS pathway. Read why ...

Buy Rating Justified by Revolution Medicines’ Promising Preclinical Data in KRAS Mutant Cancer Therapies

3d ago, source:

H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Revolution Medicines (RVMD – Research Report) today and set a price ...

Revolution Medicines to Participate in Upcoming Investor Conferences

11d ago, source:

Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., ...

Revolution Medicines Inc Ordinary Shares

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Revolutionary therapeutic shows promise for pancreatic cancer treatment

on MSN ago, source:

A new type of investigational therapeutic in development for pancreatic cancer has shown unprecedented tumor-fighting ...

Aethon Therapeutics Announces Collaboration with Revolution Medicines to Discover and Develop Novel Aethon Antibody Programs

11d ago, source: abc27

today announced that it has entered into a collaboration agreement with Revolution Medicines, Inc., a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted ...

Revolution Medicines reports breakthrough in RAS-mutant cancer treatment

7d ago, source: Investing

REDWOOD CITY, Calif. - Revolution Medicines, Inc. (NASDAQ:RVMD) has announced significant progress in the development of a new class of cancer drugs targeting RAS mutations, as revealed in two papers ...

Revolution Medicines to Participate in Upcoming Investor Conferences

11d ago, source: KTLA

REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted ...

Revolution Medicines to Participate in Upcoming Investor Conferences

12d ago, source: ADVFN

Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith ...